PMGC HOLDINGS INC. Gain (Loss) on Sale of Interest in Projects
PMGC HOLDINGS INC. (ELAB) reported Gain (Loss) on Sale of Interest in Projects of $7.54 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfInterestInProjects · last filed 2026-03-30
- PMGC HOLDINGS INC. gain (loss) on sale of interest in projects for the quarter ending 2025-12-31 was $5.00.
- PMGC HOLDINGS INC. gain (loss) on sale of interest in projects for the quarter ending 2025-09-30 was $2.91K.
- PMGC HOLDINGS INC. gain (loss) on sale of interest in projects for the quarter ending 2025-06-30 was $3.12K.
- PMGC HOLDINGS INC. gain (loss) on sale of interest in projects for the quarter ending 2025-03-31 was $1.50K.
- PMGC HOLDINGS INC. gain (loss) on sale of interest in projects for fiscal 2025 was $7.54K.
| Period end | Gain (Loss) on Sale of Interest in Projects 3 month | Gain (Loss) on Sale of Interest in Projects 6 month | Gain (Loss) on Sale of Interest in Projects 9 month | Gain (Loss) on Sale of Interest in Projects 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.92K derived: sum of 2 quarters · filed 2026-03-30 | $6.03K derived: sum of 3 quarters · filed 2026-03-30 | $7.54K 10-K · filed 2026-03-30 |
| 2025-09-30 | $2.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.03K derived: sum of 2 quarters · filed 2025-11-14 | $7.53K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $4.62K 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $1.50K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |